Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-061541
Filing Date
2019-12-20
Accepted
2019-12-20 16:18:49
Documents
2
Period of Report
2019-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1502
2 POA DOCUMENT poa.txt EX-24.3_884489 4019
  Complete submission text file 0001209191-19-061541.txt   6952
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Pande Atul (Reporting) CIK: 0001643071 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 191301747

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 6770 Blank Checks